These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 17237659)

  • 21. Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.
    Woolf CJ; Hashmi M
    Curr Opin Investig Drugs; 2004 Jan; 5(1):61-6. PubMed ID: 14983975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain.
    Fishman SM; Papazian JS; Gonzalez S; Riches PS; Gilson A
    Pain Med; 2004 Sep; 5(3):309-24. PubMed ID: 15367312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies to optimize pain management with opioids while minimizing risk of abuse.
    Brennan MJ; Stanos S
    PM R; 2010 Jun; 2(6):544-58. PubMed ID: 20630441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription opioid abuse: dental perspectives.
    Jeske AH
    Tex Dent J; 2005 Jul; 122(7):622-30. PubMed ID: 16152887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of risk-management approaches to protect patients with cancer-related pain and their healthcare providers.
    Miaskowski C
    Oncol Nurs Forum; 2008 Nov; 35 Suppl():20-4. PubMed ID: 18980936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
    Cicero TJ; Inciardi JA; Muñoz A
    J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing the benefits and reducing the harms of prescription opioid analgesics.
    Hallinan R; Osborn M; Cohen M; Dobbin M; Wodak A
    Drug Alcohol Rev; 2011 May; 30(3):315-23. PubMed ID: 21545563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing.
    Colameco S; Coren JS; Ciervo CA
    Postgrad Med; 2009 Jul; 121(4):61-6. PubMed ID: 19641271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
    Cicero TJ; Surratt H; Inciardi JA; Munoz A
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):827-40. PubMed ID: 17636553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Legal liability perspectives on abuse-deterrent opioids in the treatment of chronic pain.
    Brushwood DB; Rich BA; Coleman JJ; Bolen J; Wong W
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):333-48. PubMed ID: 21133741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDA actions to prevent prescription drug abuse.
    Jeske AH
    Tex Dent J; 2005 Jul; 122(7):634-45. PubMed ID: 16152888
    [No Abstract]   [Full Text] [Related]  

  • 33. Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain.
    Webster L; St Marie B; McCarberg B; Passik SD; Panchal SJ; Voth E
    J Opioid Manag; 2011; 7(3):235-45. PubMed ID: 21823554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practice.
    Gudin J
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):136-43. PubMed ID: 22764852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond.
    Ruan X
    Expert Opin Pharmacother; 2011 May; 12(7):999-1001. PubMed ID: 21470064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The barriers to adequate pain management with opioid analgesics.
    Hill CS
    Semin Oncol; 1993 Apr; 20(2 Suppl 1):1-5. PubMed ID: 8097339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rehabilitating opioid regulation: a prescription for the FDA's next proposal of an opioid risk evaluation and mitigation strategy (REMS).
    Homenko H
    Health Matrix Clevel; 2012; 22(1):273-313. PubMed ID: 22616548
    [No Abstract]   [Full Text] [Related]  

  • 38. What is being done to address the new drug epidemic?
    Dekker AH
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES21-6. PubMed ID: 17908827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for selecting treatment and mitigating risk in patients with chronic pain.
    Fishman SM
    J Clin Psychiatry; 2011 Jan; 72(1):e02. PubMed ID: 21272509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary: reflections on the Cicero et al. paper (PDS 06 0174.R2).
    Passik SD; Kirsh KL
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):841-4. PubMed ID: 17636554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.